Balyasny Asset Management LLC Moderna, Inc. Put Options Transaction History

Balyasny Asset Management LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $903,688 - $1.78 Million	14,200 Added 31.77%	58,900 $3.94 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $2.5 Million - $4.12 Million	24,700 Added 123.5%	44,700 $5.31 Million
Q1 2024 May 13, 2024	BUY	$85.37 - $115.44 $1.71 Million - $2.31 Million	20,000 New	20,000 $2.13 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $450,300 - $610,014	3,800 New	3,800 $461,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $131 Million - $286 Million	-590,700 Reduced 75.47%	192,000 $73.9 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $66.2 Million - $120 Million	509,700 Added 186.7%	782,700 $184 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $18.3 Million - $31.2 Million	168,000 Added 160.0%	273,000 $35.7 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $6.9 Million - $17.8 Million	105,000 New	105,000 $11 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.